The recall of the products due to exceeding safety standards for miscellaneous impurities in safety tests for the antiplatelet drugs containing the ingredient 'clopidogrel' is expanding.

The Ministry of Food and Drug Safety (MFDS) reported that a total of 29 items have been recalled until April 2, starting with Daewoong Bio’s 'Clovons Tab' on March 17.

Products containing clopidogrel bisulfate and clopidogrel sulfate are recalled. As these products are primarily contract manufacturing items, recall measures are rising.